Lateral diffusion of G s in the plasma membrane is decreased after chronic but not acute antidepressant treatment: Role of lipid raft and non-raft membrane microdomains

Neuropsychopharmacology

Volumn 40, Issue 3, 2015, Pages 766-773

  Czysz, Andrew H ^a   Schappi, Jeffrey M ^a   Rasenick, Mark M ^a,b,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; DEXAMPHETAMINE; DIAZEPAM; ESCITALOPRAM; FLUOXETINE; GUANINE NUCLEOTIDE BINDING PROTEIN; HALOPERIDOL; IMIPRAMINE; OLANZAPINE; SERTRALINE; TIANEPTINE; VENLAFAXINE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANTIDEPRESSANT ACTIVITY; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DOSE RESPONSE; EXTRACTION; GLIOMA CELL; GLIOMA CELL LINE; HALF LIFE TIME; HIGH THROUGHPUT SCREENING; LIPID RAFT; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE; ANIMAL; CELL LINE; DIFFUSION; DRUG EFFECTS; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; METABOLISM; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; CELL LINE; DIFFUSION; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; MEMBRANE MICRODOMAINS; RATS;

EID: 84922105403     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.256     Document Type: Article

References (35)

1. Allen JA, Halverson-Tamboli RA, Rasenick MM (2007). Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci 8: 128-140.
2. Allen JA, Yu JZ, Dave RH, Bhatnagar A, Roth BL, Rasenick MM (2009). Caveolin-1 and lipid microdomains regulate Gs trafficking and attenuate Gs/adenylyl cyclase signaling. Mol Pharmacol 76: 1082-1093.
3. Anderson IM (2000). Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 58: 19-36.
4. Bhatnagar A, Sheffler DJ, Kroeze WK, Compton-Toth B, Roth BL (2004). Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Gaq-coupled protein receptors. J Biol Chem 279: 34614-34623.
5. Caccia S (1998). Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications. Clin Pharmacokinet 34: 281-302.
6. Chen J, Rasenick M (1995a). Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content. J Pharmacol Exp Ther 275: 509-517.
7. Chen J, Rasenick MM (1995b). Chronic treatment of C6 glioma cells with antidepressant drugs increases functional coupling between a G protein (Gs) and adenylyl cyclase. J Neurochem 64: 724-732.
8. Dessauer CW (2009). Adenylyl cyclase-A-kinase anchoring protein complexes: the next dimension in cAMP signaling. Mol Pharmacol 76: 935-941.
9. Donati RJ, Rasenick MM (2003). G protein signaling and the molecular basis of antidepressant action. Life Sci 73: 1-17.
10. Donati RJ, Rasenick MM (2005). Chronic antidepressant treatment prevents accumulation of Gsa in cholesterol-rich, cytoskeletalassociated, plasma membrane domains (lipid rafts). Neuropsychopharmacology 30: 1238-1245.
11. Eisensamer B, Uhr M, Meyr S, Gimpl G, Deiml T, Rammes G et al (2005). Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains. J Neurosci 25: 10198-10206.
12. Fujita M, Hines CS, Zoghbi SS, Mallinger AG, Dickstein LP, Liow JS et al (2012). Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram positron emission tomography in major depressive disorder. Biol Psychiatry 72: 548-554.
13. Head BP, Patel HH, Roth DM, Murray F, Swaney JS, Niesman IR et al (2006). Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J Biol Chem 281: 26391-26399.
14. Krystal JH, Sanacora G, Duman RS (2013). Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry 73: 1133-1141.
15. Lenne P-F, Wawrezinieck L, Conchonaud F, Wurtz O, Boned A, Guo X-J et al (2006). Dynamic molecular confinement in the plasma membrane by microdomains and the cytoskeleton meshwork. EMBO J 25: 3245-3256.
16. Malberg JE, Blendy JA (2005). Antidepressant action: to the nucleus and beyond. Trends Pharmacol Sci 26: 631-638.
17. Menkes DB, Aghajanian GK, Gallager DW (1983). Chronic antidepressant treatment enhances agonist affinity of brain a1-adrenoceptors. Eur J Pharmacol 87: 35-41.
18. Musazzi L, Treccani G, Mallei A, Popoli M (2013). The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors. Biol Psychiatry 73: 1180-1188.
19. O'Donnell JM, Xu Y (2012). Evidence for global reduction in brain cyclic adenosine monophosphate signaling in depression. Biol Psychiatry 72: 524-525.
20. Ozawa H, Rasenick MM (1989). Coupling of the stimulatory GTPbinding protein Gs to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment. Mol Pharmacol 36: 803-808.
21. Ozawa H, Rasenick MM (1991). Chronic electroconvulsive treatment augments coupling of the GTP-binding protein Gs to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs. J Neurochem 56: 330-338.
22. Rasenick MM (1986). Regulation of neuronal adenylate cyclase by microtubule proteins. Ann N Y Acad Sci 466: 794-797.
23. Rasenick MM, Donati RJ, Popova JS, Yu J-Z (2004). Tubulin as a regulator of G-protein signaling. Methods Enzymol 390: 389-403.
24. Rasenick MM, Wang N (1988). Exchange of guanine nucleotides between tubulin and GTP-binding proteins that regulate adenylate cyclase: cytoskeletal modification of neuronal signal transduction. J Neurochem 51: 300-311.
25. Reits EAJ, Neefjes JJ (2001). From fixed to FRAP: measuring protein mobility and activity in living cells. Nat Cell Biol 3: E145-E147.
26. Rivera-Baltanas T, Olivares JM, Martinez-Villamarin JR, Fenton EY, Kalynchuk LE, Caruncho HJ (2014). Serotonin 2A receptor clustering in peripheral lymphocytes is altered in major depression and may be a biomarker of therapeutic efficacy. J Affect Disord 163: 47-55.
27. Rybin VO, Xu X, Lisanti MP, Steinberg SF (2000). Differential targeting of b-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. J Biol Chem 275: 41447-41457.
28. Sánchez C, Gruca P, Papp M (2003). R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model. Behav Pharmacol 14: 465-470.
29. Schappi JM, Krbanjevic A, Rasenick MM (2014). Tubulin, actin and heterotrimeric G proteins: coordination of signaling and structure. BBA-Biomembranes 1838: 674-681.
30. Thiyagarajan MM, Bigras E, Van Tol HHM, Hébert TE, Evanko D, Wedegaertner PB (2002). Activation-induced subcellular redistribution of Gas is dependent upon its unique N-terminus. Biochemistry 41: 9470-9484.
31. Toki S, Donati RJ, Rasenick MM (1999). Treatment of C6 glioma cells and rats with antidepressant drugs increases the detergent extraction of Gsa from plasma membrane. J Neurochem 73: 1114-1120.
32. Yu J-Z, Dave RH, Allen JA, Sarma T, Rasenick MM (2009). Cytosolic Gas acts as an intracellular messenger to increase microtubule dynamics and promote neurite outgrowth. J Biol Chem 284: 10462-10472.
33. Yu J-Z, Rasenick MM (2002). Real-time visualization of a fluorescent Gas: dissociation of the activated G protein from plasma membrane. Mol Pharmacol 61: 352-359.
34. Zacharias DA, Violin JD, Newton AC, Tsien RY (2002). Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 296: 913-916.
35. Zhang L, Rasenick MM (2010). Chronic treatment with escitalopram but not r-citalopram translocates Gas from lipid raft domains and potentiates adenylyl cyclase: A 5-hydroxytryptamine transporter-independent action of this antidepressant compound. J Pharmacol Exp Ther 332: 977-984.